GNOM Short Volume
Global X - Genomics & Biotechnology ETF (GNOM) operates in the Financial Services sector, specifically the Asset Management - Global industry, with a market capitalization near $51.9M, listed on NASDAQ, carrying a beta of 1.57 to the broader market. The Global X Genomics & Biotechnology ETF (GNOM) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index. public since 2019-04-10.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-05-15
- Short Volume
- 1.4K
- Total Volume
- 3.0K
- Short %
- 46.94%
- 30-Day Avg Short %
- 31.38%
Showing 30 days of FINRA short volume data for Global X - Genomics & Biotechnology ETF.
Learn how short volume is reported and how to read the data →
Frequently asked GNOM short volume questions
- What is the daily GNOM short volume?
- As of May 15, 2026, Global X - Genomics & Biotechnology ETF (GNOM) short volume is 1.4K shares against 3.0K total reported volume, or 46.94% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is GNOM short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does GNOM short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.